tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Cleo Diagnostics Advances Ovarian Cancer Test with Successful Alpha Testing
Company AnnouncementsCleo Diagnostics Advances Ovarian Cancer Test with Successful Alpha Testing
29d ago
COV
Cleo Diagnostics Partners with UCL to Advance Ovarian Cancer Test Development
PremiumCompany Announcements
Cleo Diagnostics Partners with UCL to Advance Ovarian Cancer Test Development
1M ago
COV
CLEO Diagnostics Issues New Securities to Boost Employee Incentives
PremiumCompany Announcements
CLEO Diagnostics Issues New Securities to Boost Employee Incentives
2M ago
COV
Cleo Diagnostics Secures A$845k R&D Tax Incentive for Ovarian Cancer Test Development
PremiumCompany Announcements
Cleo Diagnostics Secures A$845k R&D Tax Incentive for Ovarian Cancer Test Development
2M ago
COV
Cleo Diagnostics Advances Ovarian Cancer Test Towards Commercialization
PremiumCompany Announcements
Cleo Diagnostics Advances Ovarian Cancer Test Towards Commercialization
2M ago
COV
Cleo Diagnostics Advances Ovarian Cancer Test Development
PremiumCompany AnnouncementsCleo Diagnostics Advances Ovarian Cancer Test Development
3M ago
COV
Cleo Diagnostics Reports Reduced Losses and Advances Clinical Trials
Premium
Company Announcements
Cleo Diagnostics Reports Reduced Losses and Advances Clinical Trials
3M ago
COV
Cleo Diagnostics Clarifies Unique Market Focus and Advances in Ovarian Cancer Detection
Premium
Company Announcements
Cleo Diagnostics Clarifies Unique Market Focus and Advances in Ovarian Cancer Detection
4M ago
COV
Cleo Diagnostics Highlights Ovarian Cancer Detection Progress Amid Share Price Surge
PremiumCompany Announcements
Cleo Diagnostics Highlights Ovarian Cancer Detection Progress Amid Share Price Surge
4M ago
COV
Cleo Diagnostics Advances Ovarian Cancer Test with U.S. and Australian Trials
PremiumCompany Announcements
Cleo Diagnostics Advances Ovarian Cancer Test with U.S. and Australian Trials
4M ago
COV
Cleo Diagnostics Expands Ovarian Cancer Trial with Siles Health
PremiumCompany Announcements
Cleo Diagnostics Expands Ovarian Cancer Trial with Siles Health
6M ago
COV
Cleo Diagnostics Announces Successful AGM Resolutions
PremiumCompany Announcements
Cleo Diagnostics Announces Successful AGM Resolutions
7M ago
COV
Cleo Diagnostics Expands Ovarian Cancer Trial with Key Collaborations
PremiumCompany AnnouncementsCleo Diagnostics Expands Ovarian Cancer Trial with Key Collaborations
7M ago
COV
Cleo Diagnostics Advances in U.S. Ovarian Cancer Trials
Premium
Company Announcements
Cleo Diagnostics Advances in U.S. Ovarian Cancer Trials
8M ago
COV
Cleo Diagnostics Schedules AGM, Shareholders to Vote
Premium
Company Announcements
Cleo Diagnostics Schedules AGM, Shareholders to Vote
8M ago
COV
Cleo Diagnostics Advances Ovarian Cancer Detection
PremiumCompany Announcements
Cleo Diagnostics Advances Ovarian Cancer Detection
9M ago
COV
CLEO Diagnostics Affirms Corporate Governance Compliance
PremiumCompany Announcements
CLEO Diagnostics Affirms Corporate Governance Compliance
10M ago
COV
Cleo Diagnostics’ Losses Deepen Despite IPO
PremiumCompany Announcements
Cleo Diagnostics’ Losses Deepen Despite IPO
10M ago
COV
CLEO Advances U.S. Trials for Ovarian Cancer Test
PremiumCompany Announcements
CLEO Advances U.S. Trials for Ovarian Cancer Test
10M ago
COV
CLEO Diagnostics Advances Ovarian Cancer Test
PremiumCompany AnnouncementsCLEO Diagnostics Advances Ovarian Cancer Test
11M ago
COV
Cleo Diagnostics Advances FDA Approval Process
Premium
Company Announcements
Cleo Diagnostics Advances FDA Approval Process
12M ago
COV
CLEO Diagnostics Seeks ASX Quotation for Shares
Premium
Company Announcements
CLEO Diagnostics Seeks ASX Quotation for Shares
12M ago
COV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >